Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

News Release

 View printer-friendly version

Charles River Shanghai Facility Receives AAALAC, CCAC and SLAC Accreditations

Leading contract research organization achieves regulatory milestones

WILMINGTON, Mass.--(BUSINESS WIRE)--Oct. 7, 2009-- Charles River Laboratories, Inc. (NYSE: CRL), today announced the Company’s new Shanghai facility received accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC), the Canadian Council on Animal Care (CCAC) and the Shanghai Laboratory Animal Commission (SLAC). The AAALAC, CCAC and SLAC accreditations confirm Charles River’s ability to provide clients with superior service in a regulatory compliant environment.

“These three accreditations are a milestone in Charles River’s strategy to create a Center of Excellence in China,” said James C. Foster, President, Chairman and Chief Executive Officer of Charles River. “As the leading international CRO with GLP capabilities in China, we are replicating the Company’s high standards of research, safety, humane care and laboratory best practices that globally distinguish Charles River.”

AAALAC Recognizes Humane Care of Research Models

AAALAC International is a private, nonprofit organization that promotes the humane treatment of animals in science through voluntary accreditation and assessment programs. More than 770 companies, universities, hospitals, government agencies and other research institutions in 31 countries have earned AAALAC accreditation, demonstrating their commitment to responsible animal care and use.

The Charles River AAALAC report highlighted the Shanghai facility’s strong commitment to its animal care and use program, the state-of-the-art facility and equipment, as well as the dedicated and highly trained staff.

CCAC Acknowledges Veterinary Services

The CCAC is the Canadian national organization responsible for setting and maintaining standards for the care and use of animals in science. The Charles River Shanghai CCAC report highlighted the facility’s commendable Institutional Animal Care and Use Committee (IACUC), outstanding veterinary services, as well as its institutional education and training programs.

SLAC Praises Animal Welfare Policies

SLAC is the Shanghai regulatory body responsible for the daily administration and supervision of animals in medical research. In the SLAC audit, Charles River was commended for its excellent animal welfare policies and procedures, comprehensive emergency plan and training programs.

About Charles River

Accelerating Drug Development. Exactly. Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our approximately 8,500 employees worldwide are focused on providing clients with exactly what they need to improve and expedite the discovery, development through first-in-human evaluation, and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

Source: Charles River Laboratories, Inc.

Charles River Laboratories, Inc.
Media Contact:
Amy Cianciaruso, 781-222-6168
amy.cianciaruso@crl.com
or
Investor Contact:
Susan E. Hardy, 781-222-6190
susan.hardy@crl.com

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)